MOLN · Molecular Partners AG · Financials
Market Cap
$160.88M
Shares
38.31M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
0
-100%
FY2025
Net Income
-61.65M
-14.1%
FY2025
Operating Margin
-1231.73%
-363.5pp
FY2024
Diluted EPS
-1.65
-3.8%
FY2025
Operating Cash Flow
-51.26M
+13.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| CHF | 0 | 4.97M | 7.04M | 189.6M | 9.75M | 9.34M | 20.38M |
| CHF | 40.19M | 48.6M | 48.78M | 50.75M | 55.72M | 56.08M | 43.5M |
| CHF | -58.12M | -61.22M | -61.11M | 116.61M | -63.42M | -58.33M | -36.66M |
| CHF | 5.05M | 38K | 5.16M | 619K | 556K | 4.82M | 1.21M |
| CHF | -61.65M | -54.04M | -61.98M | 117.85M | -63.78M | -62.78M | -36.27M |
| CHF | 2000 | 2000 | 0 | 0 | 2000 | -11K | 17K |
| CHF | -61.65M | -54.04M | -61.98M | 117.85M | -63.79M | -62.76M | -36.29M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2020–FY2024: $631K in buybacks.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.